Dynamics of incidence and mortality from Hodgkin's lymphoma in the population of the Amur region (2014–2023)
https://doi.org/10.36604/1998-5029-2025-95-92-102
Abstract
Aim. To evaluate the territorial features of the main incidence and mortality indicators for malignant lymphomas in the population of the Amur Region from 2014 to 2023.
Materials and methods. This study used data from the official oncology service reports (Form 7, “Information on Malignant Neoplasms”) and mortality statistics from local branches of the Federal State Statistics Service, processed using standard oncology statistical software.
Results. In the Amur Region in 2023, there were 17.7% more new cases of malignant lymphomas registered compared to 2022. The average statistical incidence rate in 2023 among men was 2.09 ± 0.26 per 100,000 population (p = 0.190) (vs. 1.48 ± 0.25 in 2020), representing a growth rate of +108.4% since 2014. In the female population during the same year, this indicator decreased to 2.08 ± 0.37 per 100,000 (p = 0.918) (vs. 2.34 ± 0.31 in 2020), with a decline rate of –54.3% since 2014. In the structure of classical Hodgkin’s lymphoma forms, nodular sclerosis (70.3%) and mixed cellular lymphoma (23.7%) prevailed. Due to limited capacity of the oncology service in 2020–2023 under the challenging conditions of the COVID19 spread in the studied area, no actively detected cases were registered. The patient accumulation index dropped to 7.2 in 2023 (vs. 10.8 in 2021). The proportion of patients with stage I–II malignancy increased to 19.5% (vs. 12.8% in 2014), as did the share of advanced disease (20.7% vs. 2.9% in 2014). The number of morphological examinations matched the national average (100%). The average mortality rate among men was 0.55±0.07 per 100,000 population (p = 0.352) (vs. 0.51 ± 0.09 in 2020), exceeding that of women, which was 0.42 ± 0.08 (p = 0.317) (vs. 0.93 ± 0.23 in 2020). The number of patients followed for 5 years or more increased to 68.5% (vs. 56.4% in 2014), while the proportion of patients dying within the first year after diagnosis also rose to 29.0% (vs. 27.1% in 2014).
Conclusion. The insufficient level of preventive measures did not allow for more extensive active detection of malignant lymphomas between 2014 and 2023 and did not substantially improve the main indicators of medical care for this patient category in the region under study.
About the Authors
V. P. GordienkoRussian Federation
Viktor P. Gordienko, MD, PhD, DSc (Med.), Рrofessor, Head of the Department of Radiation Diagnostics and Radiation Therapy with Oncology Course
95 Gor'kogo Str., Blagoveshchensk, 675000
V. V. Voytsekhovskiy
Russian Federation
Valeriy V. Voytsekhovskiy, MD, PhD, DSc (Med.), Professor, Head of Department of Hospital Therapy with Pharmacology Course
95 Gor'kogo Str., Blagoveshchensk, 675000
Yu. V. Skabelkina
Russian Federation
Yulia V. Skabelkina, MD, Assistant of the Department of Radiation Diagnostics and Radiation Therapy with Oncology Course
95 Gor'kogo Str., Blagoveshchensk, 675000
N. A. Tovbik
Russian Federation
Natalia A. Tovbik, MD, Oncologist
110 Oktyabrʹskaya Str., Blagoveshchensk, 675000
References
1. Kaprin A.D., Starinskiy V.V., Shakhzadova A.O., editors. [Malignant neoplasms in Russia in 2023 (incidence and mortality)]. Moscow: MNIOI im. P.A. Gertsena − filial FGBU «NMITS radiologii» Minzdrava Rossii; 2024 (in Russian). ISBN 978-5-85502-298-8.
2. Kaprin A.D., Starinskiy V.V., Shakhzadova A.O., editors. [The state of oncological care to the population of Russia in 2023]. Moscow: MNIOI im. P.A. Gertsena − filial FGBU «NMITS radiologii» Minzdrava Rossii; 2024 (in Russian). ISBN 978-5-85502-297-1.
3. Kaprin A.D., Starinskiy V.V., Petrova G.V., editors. [Malignant neoplasms in Russia in 2014 (incidence and mortality)]. Moscow: MNIOI im. P.A. Gertsena − filial FGBU «NMITS radiologii» Minzdrava Rossii; 2015 (in Russian). ISBN 978-5-85502-219-3.
4. Kaprin A.D., Starinskiy V.V., Shakhzadova A.O., editors. [The state of oncological care to the population of Russia in 2014]. Moscow: MNIOI im. P.A. Gertsena − filial FGBU «NMITS radiologii» Minzdrava Rossii; 2014 (in Russian).
5. Gordienko V.P., Tovbik N.A., Rudenko D.S. [Application of modifications of prevailing drug treatment regimens in patients with malignant lymphomas (prognosis and quality of life)]. Bûlleten' fiziologii i patologii dyhaniâ = Bulletin Physiology and Pathology of Respiration 2017; 66:70-76 (in Russian). https://doi.org/10.12737/article_5a24aa0ba3f710.80842358
6. Medvedovskaya E.G. [Clinical and biological prognostic factors in Hodgkin's lymphoma: abstract of PhD thesis]. Moscow; 2018 (in Russian).
7. Demina E.A., Tumyan G.S., Moiseyeva T.N., Mikhaylova N.B., Myakova N.V., Rumyantsev A.G., Maschan A.A., Kaplanov N.D., Shmakov R.G., Falaleyeva N.A., Ptushkin V.V., Osmanov E.A., Poddubnaya I.V., Baykov V.V., Kovrigina A.M., Konovalov D.M., Trofimova V.P., Sotnikov V.M., Il′in N.V., Vinogradova Yu.N., Nechesnyuk A.V., Parkhomenko R.A., Stefanov D.N., Nevol′skikh A.A., Ivanov S.A., Khaylova Zh.V. [Hodgkin's lymphoma]. Sovremenaya onkologiya = Journal of Modern Oncology 2020; 22(2):6–33 (in Russian). https://doi.org/10.26442/18151434.2020.2.200132
8. Rukavitsyn A.A. [Hodgkin's lymphoma: new prognostic and differential diagnostic possibilities: abstract of PhD thesis]. Moscow; 2018 (in Russian).
9. Agadzhanyan N.A., Uyba V.V., Kulikova M.P., Kochetkova A.V. [Аctual problems of adaptation, ecological and restorative medicine]. Moscow: Medika; 2006 (in Russian).
10. Kulikov Yu.V., Kaminskiy N.V. [Meteogeophysical stress and ways to overcome it]. Vladivostok: Medithina DV; 2003 (in Russian).
11. Higginson J., Muir C.S., Munoz N. Human cancer epidemiology and environmental causes. Cambridge: Cambridge University Press; 1999.
12. Polyanskaya E.V. Analysis of demographic trends in the Far Eastern region (on the example of the Amur oblast). Problemy razvitiya territorii 2023; 27(3):99–112 (in Russian). https://doi.org/10.15838/ptd.2023.3.125.7
13. [Russian statistical yearbook 2023]. Moscow: Rosstat; 2023 (in Russian).
14. Merabishvili V.M. [The index accuracy – the most important criterion of an objective assessment of activity of oncological service for all localizations of malignant tumors, irrespective of level of lethality of patients]. Voprosy onkologii = Problems in Oncology 2019; 65(4):510–515 (in Russian).
15. [The Amur region in figures: short statistical book]. Blagoveshchensk: Amurstat; 2015 (in Russian).
16. Gordienko V.P. [Cancer incidence and mortality in the far eastern federal district (2013–2022)]. Sibirskiy onkologicheskiy zhurnal = Siberian Journal of Oncology 2024; 23(4):5–18 (in Russian). https://doi.org/10.21294/1814-48612024-23-4-5-18
17. Petrova G.V., Gretsova O.P., Kaprin A.D., Starinskiy V.V. [Characteristics and methods of calculating medical and statistical indicators used in oncology: methodological recommendations]. Moscow: MNIOI im. P.A. Gertsena − filial FGBU «NMITS radiologii» Minzdrava Rossii; 2014 (in Russian).
Review
For citations:
Gordienko V.P., Voytsekhovskiy V.V., Skabelkina Yu.V., Tovbik N.A. Dynamics of incidence and mortality from Hodgkin's lymphoma in the population of the Amur region (2014–2023). Bulletin Physiology and Pathology of Respiration. 2025;(95):92-102. (In Russ.) https://doi.org/10.36604/1998-5029-2025-95-92-102